Finance

Lists
Why is IOLCP down 4.36%?
Dive Deeper
IOLCP:NSE
IOL Chemicals and Pharmaceuticals Ltd
₹183.41
-4.36%
(-8.37) 1D
Nov 20, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for IOLCP...
Open
₹189.90
High
₹194.20
Low
₹183.01
Mkt. cap
53.99B
Avg. vol.
3.25M
Volume
1.72M
Dividend
0.65%
Quarterly dividend
₹0.30
Ex-dividend date
Feb 17, 2026
P/E ratio
26.51
52-wk high
₹224.00
52-wk low
₹67.19
EPS
₹6.92
Shares outstanding
56.21M
No. of employees
3K
Open
₹189.90
High
₹194.20
Low
₹183.01
Mkt. cap
53.99B
Avg. vol.
3.25M
Volume
1.72M
Dividend
0.65%
Quarterly dividend
₹0.30
Ex-dividend date
Feb 17, 2026
P/E ratio
26.51
52-wk high
₹224.00
52-wk low
₹67.19
EPS
₹6.92
Shares outstanding
56.21M
No. of employees
3K
News stories
From web sources and news partners
About IOL Chemicals and Pharmaceuticals Ltd
CEOSanjay Chaturvedi
Employees3.1K
Founded1986
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteiolcp.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.80B
6.19B
7.56B
7.95B
Cost of goods sold
3.82B
4.02B
4.78B
5.01B
Cost of revenue
3.82B
4.02B
4.78B
5.01B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
569.30M
719.60M
712.10M
687.10M
Operating expense
1.61B
1.45B
1.96B
2.06B
Total operating expenses
5.43B
5.46B
6.74B
7.08B
Operating income
371.00M
729.50M
821.50M
872.20M
Other non operating income
52.90M
-209.50M
81.80M
55.10M
EBT including unusual items
275.50M
708.10M
866.90M
872.90M
EBT excluding unusual items
387.60M
714.60M
866.90M
872.90M
Income tax expense
69.70M
176.50M
222.90M
222.20M
Effective tax rate
25.30%
24.93%
25.71%
25.46%
Other operating expenses
837.40M
522.90M
1.04B
1.16B
Net income
205.80M
531.60M
644.00M
650.70M
Net profit margin
3.55%
8.58%
8.52%
8.18%
Earnings per share
-
-
-
-
Interest and investment income
-
149.50M
-
-
Interest expense
-36.30M
-
-36.40M
-54.40M
Net interest expenses
-36.30M
149.50M
-36.40M
-54.40M
Depreciation and amortization charges
201.80M
202.90M
213.40M
222.00M
EBITDA
547.28M
929.82M
1.02B
1.09B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps